Synlogic (NASDAQ:SYBX) Stock Price Passes Above 50-Day Moving Average – Here’s What Happened

Synlogic, Inc. (NASDAQ:SYBX)’s share price crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $1.46 and traded as high as $1.58. Synlogic shares last traded at $1.45, with a volume of 5,208 shares.

Synlogic Stock Up 4.1 %

The stock’s 50-day moving average price is $1.46 and its 200 day moving average price is $1.56. The firm has a market capitalization of $16.92 million, a price-to-earnings ratio of -0.22 and a beta of 0.84.

Synlogic (NASDAQ:SYBX) last announced its quarterly earnings data on Thursday, August 8th. The biotechnology company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.51) by $0.67. Synlogic had a negative net margin of 2,284.65% and a negative return on equity of 194.73%. On average, sell-side analysts anticipate that Synlogic, Inc. will post -2.71 earnings per share for the current year.

About Synlogic

Synlogic, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout.